glp-1 news insurers Some US employers to drop coverage of obesity drugs in 2027 as use increases As insurers struggle with GLP-1

Semaglutide is offered under medical supervision, with personalized planning and follow-up to help support safe, appropriate use

Della Pepa, G., Patrcio, B

For constipation-related bloating, which is common with these medications, polyethylene glycol (Miralax) or stool softeners may be helpful if not contraindicated for the individual patient

Excessive weight regain means you spend weeks after restarting just getting back to where you were

Future Research Needs Heres what we still need to figure out: Larger, controlled clinical trials to assess asthma outcomes in patients taking GLP1 drugs Better understanding of how these therapies work in lung tissue Identification of asthma subtypes most likely to benefit Long-term safety monitoring in respiratory patients Until then, GLP1 medications should only be used within approved indications or as part of clinical studies